JUN 03, 2020 8:00 AM PDT

Vaccines for the treatment and prevention of cancer

Sponsored by: Bio-Techne
Speaker

Abstract

DATE: June 3, 2020

TIME: 8:00am PT

Cancer vaccines are increasingly being developed and tested as a cancer treatment and prevention strategy.  Designing cancer vaccines is  complicated  by a number factors including choice of antigen, immunization strategies and clinical application.  This webinar will provide detailed overview and of the various types of approaches as well as cover some recent successfully applied vaccines.

Learning objectives:

  • Basic understanding of the human immune system.
  • Basic understanding of what is being targeted in cancer vaccines.
  • Basic overview of clinical trials currently evaluating cancer vaccines.

 

Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAY 24, 2022 11:00 AM PDT
MAY 24, 2022 11:00 AM PDT
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
NOV 30, 2021 11:00 AM PST
C.E. CREDITS
NOV 30, 2021 11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
MAY 05, 2022 9:00 AM PDT
C.E. CREDITS
MAY 05, 2022 9:00 AM PDT
Date: May 5, 2022 Time: 9:00am (PDT), 12:00pm (EDT) In a time when there is global urgency around producing and deploying as many COVID-19 vaccines as...
Loading Comments...
Show Resources